Evidence mapPaperPMID 38254643Full record

ArticleBiomolecules2023

An Integrated In Silico and In Vitro Approach for the Identification of Natural Products Active against SARS-CoV-2.

Rosamaria Pennisi, Davide Gentile, Antonio Rescifina, Edoardo Napoli, Paola Trischitta, Anna Piperno, Maria Teresa Sciortino

Abstract read
In one paragraph

Article in Biomolecules, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Review
  2. MarinePharmaceuticals (Basel, Switzerland) · 2026
    Article
  3. Selective Control byInternational journal of molecular sciences · 2025
    Article
  4. Article
  5. Review
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Rosamaria PennisiDepartment of Chemical, Biological, Pharmaceutical and Environmental Science, University of Messina, Viale Ferdinando Stagno d'Alcontres 31, 98166 Messina, Italy.ORCID 0000-0003-3474-6057
Davide GentileDepartment of Chemistry, Materials and Chemical Engineering "G. Natta", Politecnico di Milano, Via Mancinelli 7, 20131 Milano, Italy.
Antonio RescifinaDepartment of Drug and Health Sciences, University of Catania, V.le A. Doria 6, 95125 Catania, Italy.ORCID 0000-0001-5039-2151
Edoardo NapoliIstituto di Chimica Biomolecolare-Consiglio Nazionale delle Ricerche, 95126 Catania, Italy.ORCID 0000-0003-4281-3256
Paola TrischittaDepartment of Chemical, Biological, Pharmaceutical and Environmental Science, University of Messina, Viale Ferdinando Stagno d'Alcontres 31, 98166 Messina, Italy.
Anna PipernoDepartment of Chemical, Biological, Pharmaceutical and Environmental Science, University of Messina, Viale Ferdinando Stagno d'Alcontres 31, 98166 Messina, Italy.
Maria Teresa SciortinoDepartment of Chemical, Biological, Pharmaceutical and Environmental Science, University of Messina, Viale Ferdinando Stagno d'Alcontres 31, 98166 Messina, Italy.ORCID 0000-0002-8519-7724

Funding

FFABR-Sciortino_Maria_Teresa_2020_II_Edizione (Italy). FFABR-Sciortino_Maria_Teresa_2020_II_Edizione (Italy).
6 · The paper itself

Abstract

Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has provoked a global health crisis due to the absence of a specific therapeutic agent. 3CL

Indexed as

Biological ProductsCOVID-19ChymasesFolic AcidHumansSARS-CoV-2Biological ProductsChymasesFolic Acidcynarinfolic acid rosmarinic acidluteolin-7-O-glucuronidenatural antiviralspseudovirusesSARS-CoV-2

Identifiers

PMID38254643
PMCPMC10813393

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.